Editor’s note: This work is part of AI Watchdog, The Atlantic’s ongoing investigation into the generative-AI industry. On Tuesday, researchers at Stanford and Yale revealed something that AI companies ...

UiPath (PATH) has been in focus after CEO Daniel Dines disclosed share sales under a pre arranged trading plan at the same time the company entered the S&P MidCap 400, which drew extra attention to ...

If you are wondering whether UiPath's share price reflects its true worth or leaves some room on the table, you are in the right place. UiPath's stock closed at US$15.88, with a 5.7% decline over the ...

In front of a George Washington University audience, however, Kennedy downplayed the budget slashing. His thesis: The administration cut bureaucracy, not research. "We’re not cutting science," Kennedy ...

UiPath Test Cloud recognized among top autonomous testing solutions with highest possible scores in vision, roadmap, and five other criteria UiPath (NYSE: PATH), a global leader in agentic automation, ...

Google today announced a “significantly more powerful Gemini Deep Research agent” that will soon be available in consumer apps and is now available for developers. Today’s announcement is focused on ...

Just in time for the holiday shopping season. Just in time for the holiday shopping season. is a NYC-based AI reporter and is currently supported by the Tarbell Center for AI Journalism. She covers ...

Reports of halted research and clinical trials contradict Health Secretary Robert F. Kennedy Jr.’s statement that the Trump administration hasn’t cut science and research. One recent research letter ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel highlighted various alleged “safety uncertainties” of the mRNA COVID-19 ...

Three years after artificial intelligence went mainstream with the release of ChatGPT, executives say their companies have yet to see a dramatic financial return from investments in the technology.